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ABSTRACT
Background: Temporal summation and conditioned pain modulation (CPM) can be measured 
using a thermode and cold pressor test (CPTest). Unfortunately, these complex and expensive 
tools are ill-suited for routine clinical assessments.
Aims: We aimed to compare the temporal summation and CPM obtained with the thermode + CPTest 
paradigm to those obtained with a novel paradigm using transcutaneous electrical nerve stimulation 
(TENS).
Methods: We assessed temporal summation and CPM in 29 healthy participants, using two 
paradigms (random order): TENS, and thermode + CPTest. In the TENS paradigm, both the 
conditioning stimulus (CS) and the test stimulus (TS) were delivered using TENS; in the thermode 
+ CPTest paradigm, the CS consisted of a CPTest and the TS was delivered using a thermode. We 
compared the average temporal summation and CPM evoked by the two paradigms.
Results: Average temporal summation was similar for both modalities (P = 0.90), and the number of 
participants showing temporal summation was similar in both paradigms (19 with thermode vs. 18 
with TENS; P = 1.00). Average CPM response was larger following the thermode + CPTest than 
following the TENS (P = 0.005), and more participants showed CPM with the thermode + CPTest 
paradigm compared to the TENS paradigm (24 vs. 14; P = 0.01).
Conclusions: Both paradigms were roughly equivalent in the ability to evoke temporal summation 
(although response to one modality did not predict response to the other), but the TENS paradigm 
appeared to be less apt to induce a CPM response than the thermode + CPTest paradigm.
RÉSUMÉ
Contexte: La sommation temporelle et la modulation de la douleur conditionnée (MDC) peuvent 
être mesurées à l’aide d’une thermode et d’un test au froid. Malheureusement, ces tests complexes 
et coûteux sont mal adaptés aux évaluations cliniques de routine.
Objectifs: Nous avons cherché à comparer la sommation temporelle et la modulation de la douleur 
conditionnée obtenues avec le paradigme thermode + test au froid à ceux obtenus avec un 
nouveau paradigme utilisant la neurostimulation électrique transcutanée (TENS).
Méthodes: Nous avons évalué la sommation temporelle et la modulation de la douleur 
conditionnée chez 29 participants en bonne santé, en utilisant les deux paradigmes (ordre 
aléatoire) : TENS, et thermode + test au froid. Dans le paradigme TENS, Le stimulus de condition-
nement et le stimulus d’essai ont été transmis à l’aide de la neurostimulation électrique 
transcutanée ; dans le paradigme thermode + test au froid, le stimulus de conditionnement 
consistait en un test au froid et le stimulus d’essai était transmis à l’aide d’une thermode. Nous 
avons comparé la sommation temporelle et la modulation de la douleur conditionnée moyennes 
évoqués par les deux paradigmes.
Résultats: La sommation temporelle moyenne était similaire pour les deux modalités (P = 0,90), et 
le nombre de participants ayant montré une sommation temporelle étaient similaires dans les deux 
paradigmes (19 avec la thermode contre 18 avec la TENS; P = 1,00). La réponse moyenne de 
modulation de la douleur conditionnée était plus importante après la thermode + test au froid 
qu’après la neurostimulation électrique transcutanée (P = 0,005), et un plus grand nombre de 
participants ont montré une modulation de la douleur conditionnée avec la thermode + test au 
froid par rapport au paradigme TENS (24 contre 14 ; P = 0,01).
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Conclusions: Les deux paradigmes sont à peu près équivalents en ce qui concerne la capacité 
d’évoquer la sommation temporelle (bien que la réaction à une modalité ne prévoie pas la réaction 
à l’autre), mais le paradigme TENS semble moins apte à induire une réponse de modulation de la 
douleur conditionnée que le paradigme thermode + test au froid.
Introduction
Chronic pain affects approximately one-fifth of the general 
population, including one-third of the elderly population.1 
A number of chronic pain conditions are characterized by 
imbalances in endogenous excitatory and/or inhibitory 
mechanisms of pain modulation.2–5 Animal studies have 
identified the specific electro-neurophysiological correlates 
of some of these mechanisms, such as wind-up (an excitatory 
mechanism of pain characterized by a progressive increase in 
dorsal horn activity observed following repeated C-fiber 
activation)6,7 and diffuse noxious inhibitory controls (an 
endogenous inhibitory mechanism of pain characterized by 
the activation of descending inhibitory projections from 
brainstem structures following a noxious stimulation, result-
ing in decreased reponses of spinal cord neurons).8,9 Human 
studies, where such electro-neurophysiological measure-
ments are much more difficult to obtain, often rely on 
behavioral correlates of these endogenous pain control 
mechanisms: for excitatory mechanisms, a phenomenon 
called “temporal summation” is often measured, wherein 
perceived pain intensity increases throughout a repetitive 
noxious stimulation of fixed intensity10,11; for inhibitory 
mechanisms, the concept of conditioned pain modulation 
(CPM) was developed, wherein a noxious stimulation 
induces widespread hypoalgesia.12,13
Imbalances in these endogenous pain modulation 
mechanisms (often in the form of increased temporal sum-
mation and/or decreased CPM, which both result in greater 
overall pain intensity)14,15 appear to correlate with response 
to certain treatments.16–18 For instance, patients with chronic 
pancreatitis presenting increased temporal summation 
respond preferentially to pregabalin,16 and patients with 
diabetic neuropathy presenting decreased CPM respond 
preferentially to duloxetine.18 Evaluating these mechanisms 
among people suffering from chronic pain could therefore 
allow clinicians to adapt the treatment to each patient 
according to the deficits observed.18–21 A paradigm often 
used to assess CPM consists of a test stimulus (TS) adminis-
tered before and after a conditioning stimulus (CS); CPM is 
measured by calculating the difference in pain levels elicited 
by the TS before and after the CS.22 Our team has developed 
a slightly modified version of this paradigm that allows for 
the assessment of temporal summation as well as CPM, by 
measuring temporal summation throughout the first TS.23,24 
In this modified CPM paradigm, the TS consists of 
a sustained moderately painful heat stimulation delivered 
for 120 s using a thermode and the CS consists of a cold 
pressor test (CPTest) wherein subjects immerse their domi-
nant forearm in a cold water bath (10°C) for 120 s. The 
continuous TS stimulation was chosen (as opposed to pulsed 
stimulations25,26; see Discussion) because our team has 
developed a specific expertise with this particular method. 
Unfortunately, although this thermode + CPTest paradigm 
is well suited to the laboratory setting, it is relatively time- 
consuming and requires complex and costly equipment27; as 
such, it is not realistic for clinicians to use it for routine 
patient assessment.
A potential alternative tool to study excitatory and inhi-
bitory mechanisms is transcutaneous electrical nerve stimu-
lation (TENS). TENS, which is frequently used in 
rehabilitation as a hypoalgesic modality,28–31 is 
a noninvasive tool that stimulates A-delta and C fibers: 
depending on the parameters, it can either block pain signals 
(high-frequency [50–100 Hz], low-intensity mode) or elicit 
a painful sensation that will trigger inhibitory mechanisms 
(low-frequency [1–5 Hz], high-intensity mode).19,32 Here, 
we hypothesized that TENS, when used in low-frequency 
and high-intensity mode, provokes a painful sensation that 
could potentially be used as both the TS and the CS in the 
CPM paradigm, replacing the thermode and CPTest. Unlike 
these tools, TENS is affordable, is easy to use, and requires 
very little time and equipment.
The objective of this exploratory study was to deter-
mine whether TENS can be used to evaluate temporal 
summation and CPM in healthy participants. More spe-
cifically, we aimed to compare the average temporal 
summation and CPM scores obtained with the two 
paradigms, to determine whether the two paradigms 
triggered these pain mechanisms in a similar number 
of participants and to assess whether response to one 
paradigm correlates with response to the other.
Methods
This study was conducted according to the Declaration 
of Helsinki. All participants provided written informed 
consent for their participation in this study. Ethics 
approval was granted from the Comité éthique de 
recherche (CÉR) du CIUSSS de l’Estrie–CHUS, 
Sherbrooke, Quebec, Canada (2019-3022).
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Participants
Participants were eligible to take part in our study if they 
were at least 18 years of age, and for women, if they were in 
their preovulatory phase, had undergone menopause, or 
were using a hormonal contraceptive (oral contraceptive, 
intrauterine device, etc.).33 Participants were excluded if 
they suffered from chronic pain, neurological disorders, or 
musculoskeletal disorders; if they had history of nonefficacy 
with TENS; or if they presented contraindications related to 
TENS (history of epilepsy, presence of a pacemaker, or metal 
implants34).
Participants were asked to refrain from taking analge-
sics during the 7 days preceding each experimental ses-
sion and to refrain from consuming caffeine and from 
doing intense physical activity during the 24 h preceding 
each experimental session.
Study Design
Study participants attended two experimental sessions at the 
Research Centre on Aging of the CIUSSS de l’Estrie–CHUS, 
during which their temporal summation and CPM response 
were assessed. In one session, this assessment was done using 
TENS; in the other, using a thermode and CPTest. Session 
order was randomized between participants (randomization 
by block of four stratified by sex, using a random number 
table). The two sessions were separated by 24 to 72 h and 
lasted approximately 1 h each. One experimenter (female 
physiotherapy student) oversaw the TENS procedure. The 
other experimenter (female pharmacology student) oversaw 
the thermode/cold pressor procedure. Both experimenters 
used standardized techniques and procedures.
Testing Sequence and Apparatus
Thermode and CPTest
We used a CPM testing procedure23 consisting of a TS 
administered before and after a CS. The TS was generated 
by a 3 cm × 3 cm thermode (TSA II, NeuroSensory Analyzer, 
Medoc Instruments, Durham, NC) applied on the nondo-
minant forearm of participants. Pain perception was 
continuously recorded with a computerized visual analog 
scale (CoVAS) linked to the thermode. The CoVAS consists 
of a mechanical slider running along a 10-cm horizontal 
track housed in a box connected to a computer. 
Participants moved the slider to reflect their pain, with the 
left track boundary identified as “no pain” (score = 0) and the 
right track boundary identified as “intolerable pain” (score = 
100). Participants were asked to continuously rate their pain 
levels by moving the slider on the device. The CoVAS 
sampling rate was set at 10 Hz. Figure 1A summarizes the 
testing sequence for the thermode + CPTest paradigm.
TENS
Unless otherwise specified, the TENS procedure was identi-
cal to the thermode + CPTest procedure outlined above. The 
TS was generated by a TENS Eclipse Plus digital apparatus 
(Empi, St. Paul, MN) with carbon electrodes (4 × 4 cm). 
TENS parameters were set as per low-frequency, high- 
intensity mode (2 Hz, 400 µs). Pain was assessed with 
a 10 cm VAS with the left boundary identified as “no pain” 
(score = 0) and the right boundary identified as “intolerable 
pain” (score = 100). The VAS was on paper and participants 
were asked to rate their pain perception by tracing a line on 
the VAS with a pencil. The VAS was preferred to the CoVAS 
because it is much cheaper and better suited to the daily 
reality of clinical practice. Pain measurements were taken at 
15, 30, 60, 90, and 120 s. Figure 1B summarizes the testing 
sequence for the TENS paradigm.
Practice Test and pretests
Thermode and CPTest Paradigm
For the practice test and pretests with the thermode, tem-
perature was gradually increased from 32°C to a maximum 
of 51°C at a rate of 0.3°C/s. One practice test was performed 
on the nondominant anterior forearm of each participant so 
that they could become familiar with the apparatus and 
nociceptive stimulus (heat stimulation). Participants were 
asked to verbally identify the point at which the heat became 
painful (pain perception threshold) and the point at which 
the pain was no longer tolerable (pain tolerance threshold). 
Figure 1. Testing sequence of the thermode + CPTest paradigm (A) and the TENS paradigm (B).
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For pretests, the thermode was placed on the nondominant 
anterior forearm of each participant, and pain was rated 
using the CoVAS. Participants were advised that the cursor 
should remain at the left boundary while they felt no pain; 
that they should start moving it toward the right when the 
heat became painful; and that the cursor should be at the 
right boundary when their pain was no longer tolerable.23 
Pretests were repeated until subjects’ pain reports were con-
sistent (within 1°C) between trials. Pretest results were used 
to identify the h_PAIN50 temperature for each participant, 
defined as the temperature eliciting a pain of 50/100. The 
h_PAIN50 temperature was used as the formal TS.
TENS Paradigm
For the practice test and pretests with TENS, the electrodes 
were placed over the sural nerve of the nondominant ankle 
and current was gradually increased from 0 mA to 
a maximum of 60 mA at a rate of 1 mA/s. The sural nerve 
was chosen instead of the forearm (which would have been 
more similar to the thermode + CPTest paradigm) because it 
is a pure sensory nerve that is not involved in voluntary 
muscle contraction (and the chosen location is not adjacent 
to muscle mass), such that its stimulation does not induce 
unpleasant and/or distracting muscle contractions. For pret-
ests, participants verbally identified the point at which the 
electrical stimulation elicited a pain level of 50/100 
e_PAIN50). Pretests were conducted twice and the average 
e_PAIN50 current was used as the formal TS. A second series 
of pretests was conducted on the dominant ankle, this time 
to identify the e_PAIN70 (current intensity at which the 
stimulation elicited a pain level of 70/100), which was used 
as the formal CS.
Test Stimulus
Thermode and CPTest Paradigm
The TS in this paradigm consisted of a noxious heat 
stimulus generated by the thermode, applied for 2 min on 
the nondominant anterior forearm at the predetermined, 
individually tailored h_PAIN50 temperature.23,24 Subjects 
were told that the thermode temperature could increase, 
remain stable, or decrease over the course of the stimula-
tion, and they were instructed to continuously record their 
pain level using the CoVAS. In fact, after a constant rise 
(0.3°C/s) from baseline (32°C) to the predetermined tem-
perature, the temperature remained fixed throughout the 
test (120 s total). The TS was administered twice: before the 
CS and after the CS. During each TS, participants were 
asked to rate their level of pain. The pre-CS TS served two 
purposes: it provided a way to evaluate temporal summa-
tion, and it served as the baseline against which post-CS TS 
scores were compared to assess CPM efficacy.
TENS Paradigm
The TS in the TENS paradigm, which served the same 
purpose as the thermode used in the thermode + CPTest 
paradigm, consisted of a noxious electrical stimulus 
generated by TENS, applied for 120 s over the sural 
nerve of the nondominant ankle at the predetermined, 
individually tailored e_PAIN50 current amplitude. 
Participants were asked to rate their pain level at 
t = 15, 30, 60, 90, and 120 s by tracing a line on a pain 
VAS. A new scale was provided at each sampling time so 
that participants did not see their previous line.
Conditioning Stimulus
Thermode and CPTest Paradigm
The CS in this paradigm consisted of a CPTest, wherein 
participants immersed their dominant forearm in a cold 
water bath for 120 s. During the CPTest, patients verbally 
rated the intensity and unpleasantness of their pain on a 100- 
point numerical pain scale (with the same anchors as the 
VAS) at t = 15, 30, 60, 90, and 120 s. These scores were used 
to calculate the average pain evoked by the CS to ensure that 
the two paradigms were comparable in terms of the average 
pain intensity evoked by the CS.
TENS Paradigm
The CS in the TENS paradigm consisted of a noxious elec-
trical stimulus generated by TENS, applied for 120 s on the 
dominant ankle (sural nerve) at the predetermined, indivi-
dually tailored e_PAIN70 current amplitude. Participants 
rated their pain as in the thermode + CPTest paradigm.
Outcome Measures: Temporal Summation
The efficacy of excitatory mechanisms was measured by 
evaluating pain fluctuations (i.e., temporal summation) 
during the pre-CS TS.23 Temporal summation can be 
measured in various ways, although most have impor-
tant drawbacks (e.g., subtracting the pain score at 30 s 
from the pain score at 120 s23 depends on two arbitrarily 
chosen points at the expense of the general trend; sub-
tracting the lowest pain score from the highest pain 
score35 risks misattributing early, nonsustained fluctua-
tions in pain scores to temporal summation). After care-
ful consideration, we elected to measure temporal 
summation as a linear regression obtained from the 
pain scores at t = 30, 60, 90, and 120 s. The slope of 
that linear regression was used as a measure of temporal 
summation, such that positive scores represented activa-
tion of excitatory mechanisms. Participants with a slope 
greater than or equal to 0.1 (corresponding to an 
increase of roughly 10 percentage points in pain scores) 
were considered to show temporal summation.
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Outcome Measures: CPM
To facilitate comparisons for pain inhibitory mechan-
isms, pain intensity ratings obtained during the 120-s TS 
were averaged, and this mean was used in subsequent 
analyses. The magnitude of CPM was obtained by sub-
tracting pre-CS TS pain scores from post-CS TS pain 
scores, such that negative values represented activation 
of inhibitory mechanisms.23
Statistical Analysis
Normality was assessed using Shapiro-Wilk tests and 
visual inspection of the data. Because normality could 
not be assumed, nonparametric tests were used. 
Temporal summation scores were averaged across par-
ticipants within each paradigm and compared between 
paradigms using Wilcoxon’s signed-rank test. The 
same analysis was conducted for CPM scores. Other 
average comparisons (e.g., average CS intensity) were 
also done using Wilcoxon’s signed-rank test. The cor-
relation between temporal summation scores obtained 
from the two paradigms was assessed with Spearman 
analysis. Again, the same analysis was done for CPM 
scores. Temporal summation scores (continuous) were 
then transformed into a dichotomic “temporal summa-
tion present/absent” score, wherein temporal summa-
tion was considered “present” if the linear regression 
obtained from pain scores had a slope of 0.1 or more 
(corresponding roughly to a pain increase of 10 percen-
tage points). McNemar’s test was carried out to identify 
whether more participants showed temporal summa-
tion in one paradigm compared to the other, and the 
relationship between the dichotomic temporal summa-
tion scores obtained with the two paradigms was 
assessed with the φ coefficient (mean square contin-
gency coefficient). Specifically, the φ coefficient was 
calculated to assess the association between 
a participant’s response to both paradigms (i.e., to 
determine whether temporal summation was consis-
tently evoked [or not] by the two modalities). CPM 
scores (continuous) were similarly transformed into 
dichotomic scores (CPM present/absent, wherein 
CPM was considered present when the delta pain 
score was less than or equal to −10, corresponding to 
a reduction of pain of at least 10 percentage points) and 
the same analyses were carried out.
The threshold of 10 percentage points was chosen for 
these transformations into dichotomic scores because 
fluctuations in pain scores less than 10 percentage points 
were considered random fluctuations and not represen-
tative of an actual change in pain perception.
In an effort to increase reproducibility and reduce the 
rate of false positives reported in the literature and to 
promote scientific rigor within the field, we embrace the 
changes proposed by Benjamin et al., wherein the 
threshold for statistical significance is lowered to P < 
0.005 and P values ranging between 0.05 and 0.005 are 
instead considered “suggestive.”36 Descriptive statistics 
are presented as means ± standard deviations in the text 
and as means ± standard errors in the figures.
Results
Participants and Baseline Data
Forty-six participants were interested in taking part in our 
study, but 11 of them did not meet eligibility criteria, so 35 
participants were invited to our experimental sessions. Six of 
these participants were later excluded for various reasons: 
failure to attend the second session; mild adverse reaction to 
TENS; no pain felt during TENS; history of nonefficacy with 
TENS; inability to withstand the CPTest for more than 15 s; 
and undisclosed neurocognitive disorder. The 29 remaining 
participants (14 men and 15 women) were aged 35 ± 18 years 
old (range: 21–71 years old). All participants complied with 
the instructions relating to medication, caffeine use, and 
physical activity prior to the experimental sessions.
The average thermode temperature used for the TS was 
46.7°C ± 2.0°C, and the average TENS current was 
37 ± 10 mA. Despite our pretests, our results suggest that 
the average pain intensity induced during the pre-CS TS was 
higher with the thermode than with the TENS (54 ± 16/100 
and 39 ± 21/100, respectively; P = 0.007). The average TENS 
current used for the CS was 38 ± 9 mA. The intensity of pain 
during the CS was 55 ± 26/100 with the CPTest and 46 ± 26/ 
100 with TENS (P = 0.06), and the unpleasantness of pain 
evoked by the CS was 67 ± 23/100 with the CPTest and 
56 ± 25/100 with the TENS (P = 0.06).
Temporal Summation
Temporal summation, calculated as the slope of the linear 
regression obtained from the pain scores during the pre-CS 
TS (at t = 30, 60, 90, and 120 s), was similar for both 
modalities (0.05 ± 0.30 with the thermode and 0.06 ± 0.16 
with the TENS; P = 0.90; see Figure 2).There was no correla-
tion (r = −0.26; P = 0.17) between the temporal summation 
(continuous variable) induced by the two modalities. To 
assess the presence or absence of temporal summation 
induced by the thermode and TENS for each participant, 
temporal summation was transformed from a continuous 
variable (slope) into a dichotomic variable (present/absent; 
see Methods). This allowed us to determine whether both 
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paradigms (or only one, or neither) evoked temporal sum-
mation in each participant (Table 1). Table 1 shows the 
response (pain mechanism present/absent) of each partici-
pant to the two paradigms (TENS vs. thermode + CPTest). 
For each pain mechanism (temporal summation (left col-
umn) and CPM (right column)), we assessed whether a 
participant’s response was the same with both modalities, 
or whether they responded to only one modality. 
Inconsistent responses (i.e., presence of temporal summa-
tion/CPM with only one of the two modalities) are high-
lighted. McNemar’s test was used to determine whether 
more participants showed temporal summation (left) and 
CPM (right) in response to one modality compared to the 
other. The φ coefficient (mean square contingency coeffi-
cient) was calculated to assess the association between parti-
cipants’ response to the two modalities, for each pain 
mechanism (temporal summation (left) and CPM (right) 
(i.e., whether a given pain mechanism is consistently evoked 
by the two modalities). The number of participants showing 
temporal summation was similar in both paradigms (19 with 
thermode vs. 18 with TENS; P = 1.00). However, there was 
no association between participants’ responses to the two 
modalities (in other words, response to one modality was not 
associated with response to the other modality; φ = −0.27; P = 
0.15). Table 2A summarizes temporal summation responses 
obtained with the two paradigms (thermode + CPTest vs. 
TENS).
Conditioned Pain Modulation
CPM, calculated by subtracting pre-CS TS pain score from 
post-CS TS pain scores, was larger following the thermode + 
CPTest than following the TENS (−11 ± 20/100 and −1 ± 12/ 
100 respectively; P = 0.005; see Figure 3). There was no 
correlation (r = 0.29; P = 0.13) between CPM scores 
(continuous variable) induced by the two modalities. To 
assess the presence or absence of CPM induced by the 
CPTest and TENS for each participant, CPM was trans-
formed from a continuous variable (delta scores) into 
a dichotomic variable (present/absent; see Methods). This 
allowed us to determine whether both paradigms (or only 
one, or neither) evoked CPM in each participant (Table 1). 
Twenty-four participants showed CPM with the thermode + 
CPTest paradigm compared to 14 with the TENS paradigm 
(P = 0.01). There was no association between participants’ 
responses to the two modalities (in other words, response to 
one modality was not associated with response to the other 
modality; φ = 0.08; P = 0.68). Table 2B summarizes CPM 
responses obtained with the two paradigms (thermode + 
CPTest vs. TENS).
Discussion
The objective of this exploratory study was to determine 
whether TENS can be used to evaluate temporal summation 
and CPM in healthy participants. More specifically, we 
aimed to compare the average temporal summation and 
CPM scores obtained with the two paradigms to determine 
whether the two paradigms triggered these pain mechanisms 
in a similar number of participants, and whether response to 
one paradigm correlates with response to the other.
Our results showed that the average temporal summation 
evoked by the two paradigms was negligible (less than 0.1) 
and similar between the two paradigms. No significant cor-
relation was found between individual temporal summation 
scores evoked by the two modalities (this negative result is 
unlikely to be due to lack of power, seeing as the correlation 
was weak). When the continuous temporal summation 
scores were transformed into dichotomic temporal summa-
tion present/absent results, the number of participants 
Figure 2. Pain scores evoked by the TS before and after the CS, for both conditions.
CANADIAN JOURNAL OF PAIN 61
showing temporal summation during the pre-CS TS was 
similar in both paradigms (roughly two-thirds of partici-
pants). However, there was no association between response 
to the two modalities, such that response to one modality was 
not associated with response to the other.
As for CPM, the thermode + CPTest paradigm, but not 
the TENS paradigm, evoked an average response that was 
substantial (larger than 10 percentage points), and average 
CPM score was significantly larger with the thermode + 
CPTest compared to the TENS. No significant correlation 
was found between individual CPM scores evoked by the 
two modalities (again, this negative result is unlikely to be 
due to lack of power, seeing as the correlation was weak). 
When the continuous CPM scores were transformed into 
Table 1. Individual CPM and TSP response to the two paradigms.






























Same response to both modalities Present with both modalities 10 12
Absent with both modalities 2 3
Different response to the two modalities Presence with thermode only 9 12
Presence with TENS only 8 2
Statistical analysis McNemar’s p p = 1.00 p = 0.01*
Phi coefficient (φ) ϕ = −0.27; P = 0.15 ϕ = 0.08; P = 0.68
*Statistically suggestive difference. **Statistically significant difference.
Table 2. Summarizes temporal summation (2A) and CPM (2B) responses obtained with the two paradigms (thermode + CPTest vs TENS).
A)
Temporal summation                                                                                             
Thermode + CPTest TENS
Average score (slope of linear regression) 0.05 ± 0.3 0.06 ± 0.16 p = 0.9
r = −0.26; p = 0.17
Participants showing temporal summation (n) 19 18 p = 1.00
ϕ = −0.27; p = 0.15
B)
CPM                                                                                                         
Thermode + CPTest TENS
Average score  (delta pain score) −11 ± 20 −1 ± 12 p = 0.005**
r = −0.29; p = 0.13
Participants showing CPM (n) 24 14 p = 0.01*
ϕ = −0.08; p = 0.68
*Statistically suggestive difference. **Statistically significant difference.
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dichotomic CPM present/absent results, the number of par-
ticipants showing CPM was larger in the thermode + CPTest 
paradigm compared to the TENS paradigm; in other words, 
the thermode + CPTest evoked CPM in a larger number of 
participants than the TENS. Moreover, there was no associa-
tion between response to the two modalities (response to one 
modality was not associated with response to the other).
Together, these results suggest that the two paradigms are 
roughly equivalent in the ability to evoke temporal summa-
tion in participants (although response to one modality was 
not associated with response to the other) but that the TENS 
paradigm is less apt to induce CPM than the thermode + 
CPTest paradigm. It is somewhat surprising that the ther-
mode + CPTest procedure did not evoke larger CPM and 
temporal summation responses on average, because 
a number of other studies have shown that thermodes and 
CPTest can in fact induce CPM23,37,38 and, to a lesser extent, 
temporal summation.23,35,39 One potential source of expla-
nation may come from our study sample, which consisted 
mostly of university students, many of whom were familiar 
with the physiology of pain. It is possible that this knowledge 
led them to form expectations regarding their pain or other-
wise influenced their pain perception. A recent study also 
observed that up to 14% of pain-free participants show no 
CPM hypoalgesia under experimental conditions.40 Should 
this lack of CPM effect be correlated with factors such as pain 
literacy, particular expectations or high levels of physical 
activity36,41–43 (factors that may have been disproportionately 
common among our participants given the homogeneity of 
our sample), our results may have been inordinately biased 
against CPM. Moreover, our TS consisted of a sustained, 
120-s noxious heat stimulus generated by the thermode. 
However, in the literature, temporal summation is often 
assessed using a pulsed (as opposed to a continuous) 
stimulation.25,44 Some authors25,45 (but not all46) have pro-
posed that a constant stimulation may actually be less 
effective than an intermittent stimulation in evoking tem-
poral summation.
One major limitation in our study concerns the difference 
in pain intensity evoked by the two paradigms. Indeed, to 
compare the outcome of the two paradigms (temporal sum-
mation and CPM), the pre-CS TS and the CS should induce 
a similar pain intensity in both paradigms. However, on 
average, we observed that the pre-CS TS induced signifi-
cantly more pain in the thermode paradigm (by 15 percen-
tage). Moreover, the CS was also more painful (by 10 
percentage points) in the thermode + CPTest paradigm 
compared to the TENS paradigm (the difference was not 
technically significant [P = 0.06] but is on the edge of the 
suggestivity threshold; though we cannot reject the null 
hypothesis and claim that there is a difference, we cannot 
claim that there is no difference either). As such, we cannot 
say whether differences in temporal summation/CPM 
reponse obtained from the two paradigms are attributable 
to these differences in pain levels or whether they arose from 
the differences in apparatus/modalities between the two 
paradigms.
Though TENS could be used instead of a thermode to 
measure temporal summation (but not CPM) in a clinical 
setting, readers should keep in mind that many of our 
participants responded only to one modality and not the 
other. These results are important because many studies 
assess temporal summation/CPM (for example, aiming to 
identify personal characteristics associated with the presence/ 
absence of these mechanisms) using only a single 
modality.18,23,38 These studies tend to conclude that 
a certain subset of participants have deficient CPM or 
increased temporal summation. However, it may be that 
the mechanisms are not themselves deficient; they are simply 
less responsive to certain stimulations. Moreover, because 
some of our participants showed temporal summation in 
response to one modality but not the other, clinicians seeking 
Figure 3. Average pain levels elicited by the thermode and TENS throughout the duration of the pre-CS TS. The linear regression (obtained from 
the pain scores at t=30, 60, 90 and 120 seconds) is shown for both paradigms. The slope of the linear regression represents temporal summation. 
Figure 3B shows the magnitude of CPM, calculated as the difference between post-CS and pre-CS pain scores.
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to assess the presence of temporal summation in their parti-
cipants in order to recommend a pharmacological treatment 
should choose their assessing modality carefully. Indeed, 
a stream of studies has started to assess the response of 
patients to certain classes of medication based on endogen-
ous pain responses.16,18,21 Clinicians should therefore ensure 
that their clinical assessment of temporal summation is made 
using the same modality as the study they are basing their 
recommendations on.
Conclusion
In conclusion, our results suggest that the two paradigms are 
roughly equivalent in the ability to evoke temporal summa-
tion in participants but that the TENS paradigm is less apt to 
induce CPM than the thermode + CPTest paradigm. 
Importantly, response to one modality did not predict 
response to another modality (especially in the case of tem-
poral summation), such that conclusions regarding the pre-
sence/absence of endogenous pain mechanisms in certain 
individuals should be interpreted with caution and drawn 
preferably from studies using multiple modalities.
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Outcome Measures: CPM
To facilitate comparisons for pain inhibitory mechan-
isms, pain intensity ratings obtained during the 120-s TS 
were averaged, and this mean was used in subsequent 
analyses. The magnitude of CPM was obtained by sub-
tracting pre-CS TS pain scores from post-CS TS pain 
scores, such that negative values represented activation 
of inhibitory mechanisms.23
Statistical Analysis
Normality was assessed using Shapiro-Wilk tests and 
visual inspection of the data. Because normality could 
not be assumed, nonparametric tests were used. 
Temporal summation scores were averaged across par-
ticipants within each paradigm and compared between 
paradigms using Wilcoxon’s signed-rank test. The 
same analysis was conducted for CPM scores. Other 
average comparisons (e.g., average CS intensity) were 
also done using Wilcoxon’s signed-rank test. The cor-
relation between temporal summation scores obtained 
from the two paradigms was assessed with Spearman 
analysis. Again, the same analysis was done for CPM 
scores. Temporal summation scores (continuous) were 
then transformed into a dichotomic “temporal summa-
tion present/absent” score, wherein temporal summa-
tion was considered “present” if the linear regression 
obtained from pain scores had a slope of 0.1 or more 
(corresponding roughly to a pain increase of 10 percen-
tage points). McNemar’s test was carried out to identify 
whether more participants showed temporal summa-
tion in one paradigm compared to the other, and the 
relationship between the dichotomic temporal summa-
tion scores obtained with the two paradigms was 
assessed with the φ coefficient (mean square contin-
gency coefficient). Specifically, the φ coefficient was 
calculated to assess the association between 
a participant’s response to both paradigms (i.e., to 
determine whether temporal summation was consis-
tently evoked [or not] by the two modalities). CPM 
scores (continuous) were similarly transformed into 
dichotomic scores (CPM present/absent, wherein 
CPM was considered present when the delta pain 
score was less than or equal to −10, corresponding to 
a reduction of pain of at least 10 percentage points) and 
the same analyses were carried out.
The threshold of 10 percentage points was chosen for 
these transformations into dichotomic scores because 
fluctuations in pain scores less than 10 percentage points 
were considered random fluctuations and not represen-
tative of an actual change in pain perception.
In an effort to increase reproducibility and reduce the 
rate of false positives reported in the literature and to 
promote scientific rigor within the field, we embrace the 
changes proposed by Benjamin et al., wherein the 
threshold for statistical significance is lowered to P < 
0.005 and P values ranging between 0.05 and 0.005 are 
instead considered “suggestive.”36 Descriptive statistics 
are presented as means ± standard deviations in the text 
and as means ± standard errors in the figures.
Results
Participants and Baseline Data
Forty-six participants were interested in taking part in our 
study, but 11 of them did not meet eligibility criteria, so 35 
participants were invited to our experimental sessions. Six of 
these participants were later excluded for various reasons: 
failure to attend the second session; mild adverse reaction to 
TENS; no pain felt during TENS; history of nonefficacy with 
TENS; inability to withstand the CPTest for more than 15 s; 
and undisclosed neurocognitive disorder. The 29 remaining 
participants (14 men and 15 women) were aged 35 ± 18 years 
old (range: 21–71 years old). All participants complied with 
the instructions relating to medication, caffeine use, and 
physical activity prior to the experimental sessions.
The average thermode temperature used for the TS was 
46.7°C ± 2.0°C, and the average TENS current was 
37 ± 10 mA. Despite our pretests, our results suggest that 
the average pain intensity induced during the pre-CS TS was 
higher with the thermode than with the TENS (54 ± 16/100 
and 39 ± 21/100, respectively; P = 0.007). The average TENS 
current used for the CS was 38 ± 9 mA. The intensity of pain 
during the CS was 55 ± 26/100 with the CPTest and 46 ± 26/ 
100 with TENS (P = 0.06), and the unpleasantness of pain 
evoked by the CS was 67 ± 23/100 with the CPTest and 
56 ± 25/100 with the TENS (P = 0.06).
Temporal Summation
Temporal summation, calculated as the slope of the linear 
regression obtained from the pain scores during the pre-CS 
TS (at t = 30, 60, 90, and 120 s), was similar for both 
modalities (0.05 ± 0.30 with the thermode and 0.06 ± 0.16 
with the TENS; P = 0.90; see Figure 2).There was no correla-
tion (r = −0.26; P = 0.17) between the temporal summation 
(continuous variable) induced by the two modalities. To 
assess the presence or absence of temporal summation 
induced by the thermode and TENS for each participant, 
temporal summation was transformed from a continuous 
variable (slope) into a dichotomic variable (present/absent; 
see Methods). This allowed us to determine whether both 
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paradigms (or only one, or neither) evoked temporal sum-
mation in each participant (Table 1). Table 1 shows the 
response (pain mechanism present/absent) of each partici-
pant to the two paradigms (TENS vs. thermode + CPTest). 
For each pain mechanism (temporal summation (left col-
umn) and CPM (right column)), we assessed whether a 
participant’s response was the same with both modalities, 
or whether they responded to only one modality. 
Inconsistent responses (i.e., presence of temporal summa-
tion/CPM with only one of the two modalities) are high-
lighted. McNemar’s test was used to determine whether 
more participants showed temporal summation (left) and 
CPM (right) in response to one modality compared to the 
other. The φ coefficient (mean square contingency coeffi-
cient) was calculated to assess the association between parti-
cipants’ response to the two modalities, for each pain 
mechanism (temporal summation (left) and CPM (right) 
(i.e., whether a given pain mechanism is consistently evoked 
by the two modalities). The number of participants showing 
temporal summation was similar in both paradigms (19 with 
thermode vs. 18 with TENS; P = 1.00). However, there was 
no association between participants’ responses to the two 
modalities (in other words, response to one modality was not 
associated with response to the other modality; φ = −0.27; P = 
0.15). Table 2A summarizes temporal summation responses 
obtained with the two paradigms (thermode + CPTest vs. 
TENS).
Conditioned Pain Modulation
CPM, calculated by subtracting pre-CS TS pain score from 
post-CS TS pain scores, was larger following the thermode + 
CPTest than following the TENS (−11 ± 20/100 and −1 ± 12/ 
100 respectively; P = 0.005; see Figure 3). There was no 
correlation (r = 0.29; P = 0.13) between CPM scores 
(continuous variable) induced by the two modalities. To 
assess the presence or absence of CPM induced by the 
CPTest and TENS for each participant, CPM was trans-
formed from a continuous variable (delta scores) into 
a dichotomic variable (present/absent; see Methods). This 
allowed us to determine whether both paradigms (or only 
one, or neither) evoked CPM in each participant (Table 1). 
Twenty-four participants showed CPM with the thermode + 
CPTest paradigm compared to 14 with the TENS paradigm 
(P = 0.01). There was no association between participants’ 
responses to the two modalities (in other words, response to 
one modality was not associated with response to the other 
modality; φ = 0.08; P = 0.68). Table 2B summarizes CPM 
responses obtained with the two paradigms (thermode + 
CPTest vs. TENS).
Discussion
The objective of this exploratory study was to determine 
whether TENS can be used to evaluate temporal summation 
and CPM in healthy participants. More specifically, we 
aimed to compare the average temporal summation and 
CPM scores obtained with the two paradigms to determine 
whether the two paradigms triggered these pain mechanisms 
in a similar number of participants, and whether response to 
one paradigm correlates with response to the other.
Our results showed that the average temporal summation 
evoked by the two paradigms was negligible (less than 0.1) 
and similar between the two paradigms. No significant cor-
relation was found between individual temporal summation 
scores evoked by the two modalities (this negative result is 
unlikely to be due to lack of power, seeing as the correlation 
was weak). When the continuous temporal summation 
scores were transformed into dichotomic temporal summa-
tion present/absent results, the number of participants 
Figure 2. Pain scores evoked by the TS before and after the CS, for both conditions.
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showing temporal summation during the pre-CS TS was 
similar in both paradigms (roughly two-thirds of partici-
pants). However, there was no association between response 
to the two modalities, such that response to one modality was 
not associated with response to the other.
As for CPM, the thermode + CPTest paradigm, but not 
the TENS paradigm, evoked an average response that was 
substantial (larger than 10 percentage points), and average 
CPM score was significantly larger with the thermode + 
CPTest compared to the TENS. No significant correlation 
was found between individual CPM scores evoked by the 
two modalities (again, this negative result is unlikely to be 
due to lack of power, seeing as the correlation was weak). 
When the continuous CPM scores were transformed into 
Table 1. Individual CPM and TSP response to the two paradigms.






























Same response to both modalities Present with both modalities 10 12
Absent with both modalities 2 3
Different response to the two modalities Presence with thermode only 9 12
Presence with TENS only 8 2
Statistical analysis McNemar’s p p = 1.00 p = 0.01*
Phi coefficient (φ) = −0.27; P = 0.15 = 0.08; P = 0.68
*Statistically suggestive difference. **Statistically significant difference.
Table 2. Summarizes temporal summation (2A) and CPM (2B) responses obtained with the two paradigms (thermode + CPTest vs TENS).
A)
Temporal summation                                                                                             
Thermode + CPTest TENS
Average score (slope of linear regression) 0.05 ± 0.3 0.06 ± 0.16 p = 0.9
r = −0.26; p = 0.17
Participants showing temporal summation (n) 19 18 p = 1.00
= −0.27; p = 0.15
B)
CPM                                                                                                         
Thermode + CPTest TENS
Average score  (delta pain score) −11 ± 20 −1 ± 12 p = 0.005**
r = −0.29; p = 0.13
Participants showing CPM (n) 24 14 p = 0.01*
= −0.08; p = 0.68
*Statistically suggestive difference. **Statistically significant difference.
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dichotomic CPM present/absent results, the number of par-
ticipants showing CPM was larger in the thermode + CPTest 
paradigm compared to the TENS paradigm; in other words, 
the thermode + CPTest evoked CPM in a larger number of 
participants than the TENS. Moreover, there was no associa-
tion between response to the two modalities (response to one 
modality was not associated with response to the other).
Together, these results suggest that the two paradigms are 
roughly equivalent in the ability to evoke temporal summa-
tion in participants (although response to one modality was 
not associated with response to the other) but that the TENS 
paradigm is less apt to induce CPM than the thermode + 
CPTest paradigm. It is somewhat surprising that the ther-
mode + CPTest procedure did not evoke larger CPM and 
temporal summation responses on average, because 
a number of other studies have shown that thermodes and 
CPTest can in fact induce CPM23,37,38 and, to a lesser extent, 
temporal summation.23,35,39 One potential source of expla-
nation may come from our study sample, which consisted 
mostly of university students, many of whom were familiar 
with the physiology of pain. It is possible that this knowledge 
led them to form expectations regarding their pain or other-
wise influenced their pain perception. A recent study also 
observed that up to 14% of pain-free participants show no 
CPM hypoalgesia under experimental conditions.40 Should 
this lack of CPM effect be correlated with factors such as pain 
literacy, particular expectations or high levels of physical 
activity36,41–43 (factors that may have been disproportionately 
common among our participants given the homogeneity of 
our sample), our results may have been inordinately biased 
against CPM. Moreover, our TS consisted of a sustained, 
120-s noxious heat stimulus generated by the thermode. 
However, in the literature, temporal summation is often 
assessed using a pulsed (as opposed to a continuous) 
stimulation.25,44 Some authors25,45 (but not all46) have pro-
posed that a constant stimulation may actually be less 
effective than an intermittent stimulation in evoking tem-
poral summation.
One major limitation in our study concerns the difference 
in pain intensity evoked by the two paradigms. Indeed, to 
compare the outcome of the two paradigms (temporal sum-
mation and CPM), the pre-CS TS and the CS should induce 
a similar pain intensity in both paradigms. However, on 
average, we observed that the pre-CS TS induced signifi-
cantly more pain in the thermode paradigm (by 15 percen-
tage). Moreover, the CS was also more painful (by 10 
percentage points) in the thermode + CPTest paradigm 
compared to the TENS paradigm (the difference was not 
technically significant [P = 0.06] but is on the edge of the 
suggestivity threshold; though we cannot reject the null 
hypothesis and claim that there is a difference, we cannot 
claim that there is no difference either). As such, we cannot 
say whether differences in temporal summation/CPM 
reponse obtained from the two paradigms are attributable 
to these differences in pain levels or whether they arose from 
the differences in apparatus/modalities between the two 
paradigms.
Though TENS could be used instead of a thermode to 
measure temporal summation (but not CPM) in a clinical 
setting, readers should keep in mind that many of our 
participants responded only to one modality and not the 
other. These results are important because many studies 
assess temporal summation/CPM (for example, aiming to 
identify personal characteristics associated with the presence/ 
absence of these mechanisms) using only a single 
modality.18,23,38 These studies tend to conclude that 
a certain subset of participants have deficient CPM or 
increased temporal summation. However, it may be that 
the mechanisms are not themselves deficient; they are simply 
less responsive to certain stimulations. Moreover, because 
some of our participants showed temporal summation in 
response to one modality but not the other, clinicians seeking 
Figure 3. Average pain levels elicited by the thermode and TENS throughout the duration of the pre-CS TS. The linear regression (obtained from 
the pain scores at t=30, 60, 90 and 120 seconds) is shown for both paradigms. The slope of the linear regression represents temporal summation. 
Figure 3B shows the magnitude of CPM, calculated as the difference between post-CS and pre-CS pain scores.
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to assess the presence of temporal summation in their parti-
cipants in order to recommend a pharmacological treatment 
should choose their assessing modality carefully. Indeed, 
a stream of studies has started to assess the response of 
patients to certain classes of medication based on endogen-
ous pain responses.16,18,21 Clinicians should therefore ensure 
that their clinical assessment of temporal summation is made 
using the same modality as the study they are basing their 
recommendations on.
Conclusion
In conclusion, our results suggest that the two paradigms are 
roughly equivalent in the ability to evoke temporal summa-
tion in participants but that the TENS paradigm is less apt to 
induce CPM than the thermode + CPTest paradigm. 
Importantly, response to one modality did not predict 
response to another modality (especially in the case of tem-
poral summation), such that conclusions regarding the pre-
sence/absence of endogenous pain mechanisms in certain 
individuals should be interpreted with caution and drawn 
preferably from studies using multiple modalities.
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